Shingles is awful, but there may be another reason to get vaccinated. It may fight dementia
Shingrix is a onetime vaccination, given in two doses a few months apart. The CDC recommends it starting at age 50 for most ...
New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops
A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.
GSK: Under Threat From 'Double Whammy' Of Vaccine Skepticism And Pharma Tariffs
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
Shingles vaccine may also cut risk of dementia, study shows
A vaccine to fight dementia? It turns out there may already be one – shots that prevent painful shingles also appear to ...
Shingles Vaccine Can Decrease Risk of Dementia, Study Finds
Several previous studies have suggested that shingles vaccinations might reduce dementia risk, but most could not exclude the ...
Does the shingles jab slash your risk of dementia?
The trailblazing study will use the data from up to 1.4million NHS patients to test whether its shingles vaccine reduces the ...
pharmaphorum14d
Shingrix and Trelegy shield GSK from Advair fallout
GlaxoSmithKline is expecting flat earnings this year, having earlier forecast a decline, as rising sales of new drugs have helped offset the impact of generics on its Advair blockbuster in the US.